Related Experiment Video
Updated: Sep 30, 2026
Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
[Preparation and characterization of monoclonal antibodies against Cryptosporidium parvum]
1Department of Pediatrics, Xinqiao Hospital, Third Military Medical University, Chongqing 400037.
Aim:
To develop and characterize the monoclonal antibodies(McAbs) against Cryptosporidium parvum (C. parvum).
Methods:
BALB/c mice were immunized with purified oocyst antigens of C. parvum from human isolates and McAbs against C. parvum were prepared by using hybridoma technique. The characterization of McAbs was studied by means of indirect immunofluorescent assay (IFA) and Western blot analysis.
Results:
Four clones of hybridoma cell lines secreting McAbs against oocyst antigens of C. parvum were obtained. The immunoglobulin subclasses of these four McAbs were identified as IgM (Z4C8,Z3D7) and IgG1(Z2B6,Z3D2) and their light chains were kappa chain. IFA results showed that three McAb (Z4C8, Z3D7 and Z3D2) conjugates produced a diffuse fluorescence in the Cryptosporidium sporozoites (CSP) and one (Z2B6) produced local fluorescence in the oocyst wall of C. parvum. Four McAbs could recognize 4 of 42 polypeptide antigen bands of CSP with molecular weights of 20.5 kDa, 33 kDa, 60.5 kDa and 95 kDa, among which both Z4C8 and Z3D7 could recognize 20.5 kDa band that was defined as a principal antigenic protein of CSP.
Conclusion:
These four McAbs possess their own characteristics of recognizing antigenic epitopes on CSP, but react specifically against antigens of C. parvum.
Insights
Researchers developed four monoclonal antibodies (McAbs) targeting Cryptosporidium parvum (C. parvum) antigens. These McAbs specifically recognize key proteins on the parasite, aiding in diagnostic and therapeutic strategies against C. parvum infections.
Area of Science:
- Immunology
- Parasitology
- Biotechnology
Background:
- Cryptosporidium parvum (C. parvum) is a significant cause of diarrheal disease, particularly in immunocompromised individuals.
- Effective diagnostic and therapeutic tools against C. parvum are crucial for public health.
Purpose of the Study:
- To develop and characterize novel monoclonal antibodies (McAbs) against C. parvum.
- To identify specific antigenic targets of C. parvum using these McAbs.
Main Methods:
- Hybridoma technology was employed to generate McAbs from mice immunized with C. parvum oocyst antigens.
- Indirect immunofluorescence assay (IFA) and Western blot analysis were used for McAb characterization and antigen recognition studies.
Main Results:
- Four hybridoma cell lines producing McAbs (Z4C8, Z3D7, Z2B6, Z3D2) against C. parvum oocyst antigens were successfully established.
- McAbs recognized specific molecular weight antigens (20.5 kDa, 33 kDa, 60.5 kDa, 95 kDa) on C. parvum sporozoites (CSP), with Z4C8 and Z3D7 targeting a 20.5 kDa principal antigenic protein.
- IFA confirmed McAb reactivity against CSP, with distinct fluorescence patterns indicating different epitope specificities.
Conclusions:
- The developed McAbs exhibit specific reactivity against C. parvum antigens, highlighting their potential utility.
- These McAbs recognize distinct antigenic epitopes on C. parvum sporozoites, offering valuable tools for C. parvum research and diagnostics.
